Exact Mass: 330.0586718

Exact Mass Matches: 330.0586718

Found 53 metabolites which its exact mass value is equals to given mass value 330.0586718, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Aluminium acetoacetate

Aluminium acetoacetate

C12H15AlO9 (330.053145)


A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02A - Antacids > A02AB - Aluminium compounds

   

5-Hydroxydantrolene

4,5-dihydroxy-1-[(E)-{[5-(4-nitrophenyl)furan-2-yl]methylidene}amino]-2,5-dihydro-1H-imidazol-2-one

C14H10N4O6 (330.060032)


5-Hydroxydantrolene is a metabolite of dantrolene. Dantrolene sodium is a muscle relaxant that acts by abolishing excitation-contraction coupling in muscle cells, probably by action on the ryanodine receptor. It is the only specific and effective treatment for malignant hyperthermia, a rare, life-threatening disorder triggered by general anesthesia. (Wikipedia)

   

6-(4-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(4-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.05869440000004)


6-(4-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 3,4-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

6-(5-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(5-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.05869440000004)


6-(5-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 3,4-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

6-(4-carboxy-3-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(4-carboxy-3-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.05869440000004)


6-(4-carboxy-3-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 2,4-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

6-(2-carboxy-5-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(2-carboxy-5-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.05869440000004)


6-(2-carboxy-5-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 2,4-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

6-(3-carboxy-5-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(3-carboxy-5-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.05869440000004)


6-(3-carboxy-5-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 3,5-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

6-(3-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(3-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.05869440000004)


6-(3-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 2,3-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

6-(2-carboxy-6-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(2-carboxy-6-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.05869440000004)


6-(2-carboxy-6-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 2,3-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

6-(3-carboxy-4-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(3-carboxy-4-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.05869440000004)


6-(3-carboxy-4-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 2,5-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

6-(2-carboxy-4-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(2-carboxy-4-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.05869440000004)


6-(2-carboxy-4-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 2,5-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

5-Hydroxy Dantrolene

5-hydroxy-1-({[5-(4-nitrophenyl)furan-2-yl]methylidene}amino)imidazolidine-2,4-dione

C14H10N4O6 (330.060032)


   

Pirazolac

2-[4-(4-chlorophenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl]acetic acid

C17H12ClFN2O2 (330.05712939999995)


   
   
   
   

C1=CC(OC)=CC=C1CCC1=CC(=O)C2=CC(O)=CC(Cl)=C2O1

C1=CC(OC)=CC=C1CCC1=CC(=O)C2=CC(O)=CC(Cl)=C2O1

C18H15ClO4 (330.06588200000004)


   

5-HYDROXYDANTROLENE

5-HYDROXYDANTROLENE

C14H10N4O6 (330.060032)


   

METHYL 1-TOSYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE

METHYL 1-TOSYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE

C16H14N2O4S (330.06742440000005)


   

methyl 1-(4-methylphenyl)sulfonylpyrrolo[3,2-b]pyridine-2-carboxylate

methyl 1-(4-methylphenyl)sulfonylpyrrolo[3,2-b]pyridine-2-carboxylate

C16H14N2O4S (330.06742440000005)


   

3-allyl-5-(4-methoxyphenyl)-2-sulfanylthieno[2,3-d]pyrimidin-4(3h)-one

3-allyl-5-(4-methoxyphenyl)-2-sulfanylthieno[2,3-d]pyrimidin-4(3h)-one

C16H14N2O2S2 (330.0496664)


   
   

ETHYL 1-(PHENYLSULFONYL)-1H-PYRROLO[2,3-B]PYRIDINE-2-CARBOXYLATE

ETHYL 1-(PHENYLSULFONYL)-1H-PYRROLO[2,3-B]PYRIDINE-2-CARBOXYLATE

C16H14N2O4S (330.06742440000005)


   

sodium,[4-[2-(4-hydroxyphenyl)propan-2-yl]phenyl] sulfate

sodium,[4-[2-(4-hydroxyphenyl)propan-2-yl]phenyl] sulfate

C15H15NaO5S (330.053786)


   

1H-Pyrrolo[2,3-b]pyridine-3-carboxylic acid, 1-(phenylsulfonyl)-, ethyl ester

1H-Pyrrolo[2,3-b]pyridine-3-carboxylic acid, 1-(phenylsulfonyl)-, ethyl ester

C16H14N2O4S (330.06742440000005)


   

1-(3,4-DIMETHYLPHENYL)-3-METHYL-3-PYRAZOLIN-5-ONE

1-(3,4-DIMETHYLPHENYL)-3-METHYL-3-PYRAZOLIN-5-ONE

C15H8F6N2 (330.05916399999995)


   

calcium,5-phenyl-1,2,3-triaza-4-azanidacyclopenta-2,5-diene

calcium,5-phenyl-1,2,3-triaza-4-azanidacyclopenta-2,5-diene

C14H10CaN8 (330.065429)


   

ETHYL 6,6-DIMETHYL-3-(METHYLSULFONYL)-4-OXO-4,5,6,7-TETRAHYDROBENZO[C]THIOPHENE-1-CARBOXYLATE

ETHYL 6,6-DIMETHYL-3-(METHYLSULFONYL)-4-OXO-4,5,6,7-TETRAHYDROBENZO[C]THIOPHENE-1-CARBOXYLATE

C14H18O5S2 (330.0595618)


   

2-BENZYLAMINO-5-TRIFLUOROMETHYL-BENZENESULFONAMIDE

2-BENZYLAMINO-5-TRIFLUOROMETHYL-BENZENESULFONAMIDE

C14H13F3N2O2S (330.0649794)


   

Pirazolac

Pirazolac

C17H12ClFN2O2 (330.05712939999995)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

6-Chloro-5-(2-methoxyphenoxy)-2,2-bipyrimidin-4(5H)-one

6-Chloro-5-(2-methoxyphenoxy)-2,2-bipyrimidin-4(5H)-one

C15H11ClN4O3 (330.0519646)


   

Plumbane,chlorotriethyl-

Plumbane,chlorotriethyl-

C6H15ClPb (330.062863)


   

((2-bromo-5-methoxybenzyl)oxy)(tert-butyl)dimethylsilane

((2-bromo-5-methoxybenzyl)oxy)(tert-butyl)dimethylsilane

C14H23BrO2Si (330.0650598)


   

Methyl 2-[4-(methylsulfonyl)phenyl]imidazo[1,2-a]pyridine-6-carboxylate

Methyl 2-[4-(methylsulfonyl)phenyl]imidazo[1,2-a]pyridine-6-carboxylate

C16H14N2O4S (330.06742440000005)


   

6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one

6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one

C17H12ClFN2O2 (330.05712939999995)


   

alpha-Ribazole-5-phosphate derivative

alpha-Ribazole-5-phosphate derivative

C12H15N2O7P (330.061685)


   

6-(5-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(5-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.05869440000004)


6-(5-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 3,4-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   
   

3-amino-4,6-dimethyl-N-(2-thienylmethylene)thieno[2,3-b]pyridine-2-carbohydrazide

3-amino-4,6-dimethyl-N-(2-thienylmethylene)thieno[2,3-b]pyridine-2-carbohydrazide

C15H14N4OS2 (330.0608994)


   

N-[4-(6-chloro-5-nitro-1H-benzimidazol-2-yl)phenyl]acetamide

N-[4-(6-chloro-5-nitro-1H-benzimidazol-2-yl)phenyl]acetamide

C15H11ClN4O3 (330.0519646)


   

2-(4-fluorophenoxy)-N-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)acetamide

2-(4-fluorophenoxy)-N-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)acetamide

C15H11FN4O2S (330.0586718)


   

N-[3-(1,3-benzothiazol-2-yl)-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl]acetamide

N-[3-(1,3-benzothiazol-2-yl)-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl]acetamide

C16H14N2O2S2 (330.0496664)


   

N-propyl-N-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)-2-thiophenecarboxamide

N-propyl-N-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)-2-thiophenecarboxamide

C15H14N4OS2 (330.0608994)


   

5-[(4,7-dihydroxy-2-oxochromen-3-yl)carbamoyl]-1H-pyrrole-2-carboxylic acid

5-[(4,7-dihydroxy-2-oxochromen-3-yl)carbamoyl]-1H-pyrrole-2-carboxylic acid

C15H10N2O7 (330.04879900000003)


   
   

6-(2-Formyl-3,5-dihydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(2-Formyl-3,5-dihydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.05869440000004)


   

3,4-Dihydroxybenzoic acid 3-O-beta-D-glucuronide

3,4-Dihydroxybenzoic acid 3-O-beta-D-glucuronide

C13H14O10 (330.05869440000004)


   

6-(4-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(4-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.05869440000004)


   

6-(4-carboxy-3-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(4-carboxy-3-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.05869440000004)


   

6-(3-carboxy-4-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(3-carboxy-4-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.05869440000004)


   

cacibiocin A

cacibiocin A

C15H10N2O7 (330.04879900000003)


An aminocoumarin resulting from the formal condensation of one of the carboxy groups of pyrrole-2,5-dicarboxylic acid with the amino group of 3-amino-4,7-dihydroxycoumarin. It is a natural product isolated from Catenulispora acidiphila that doesnt exhibit an antimicrobial activity contrary to most aminocoumarins.

   

4,7,9-trihydroxybenzo[j]fluoranthene-3,8-dione

4,7,9-trihydroxybenzo[j]fluoranthene-3,8-dione

C20H10O5 (330.052821)